MedPath

Inulin * a potential preventive dietary supplement against PPI induced hypomagnesemia

Conditions
hypomagnesemia
magnesium shortage
PPI induced hypomagmagnesemia
10025477
10014412
Registration Number
NL-OMON38331
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

The use of PPIs (protonpump inhibitors, type omeprazol) and having hypomagnesemia as defined by serum Mg2+ < 0.7 mmol/L.

Exclusion Criteria

Unstable health conditions, patients that have stopped the PPI, acutely ill patients.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath